Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes

Neuronetics

Summary

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Eligibility

Age range: 5–120 years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date of November 01, 2008 or later. Exclusion Criteria: • Incomplete information on treatment parameters

Interventions

Device
NeuroStar Advanced TMS Therapy System
non-invasive brain stimulation device

Location

Neuronetics
Malvern, Pennsylvania

Summary

Eligibility

Interventions

Location

Conditions